BACKGROUND: Pancreatic-duodenal homeobox 1 (PDX-1) is a transcription factor that regulates embryologic pancreas development and insulin expression in the adult islet; however, it is overexpressed in many types of cancer, including pancreatic cancer. The purpose of this study was to investigate the role of PDX-1 in tumorigenesis in human cells. METHODS: In vitro cell proliferation, invasion, and transformation were performed in human embryonic kidney cell line (HEK 293), pancreatic cancer cell line MIA PaCa2, and human pancreatic ductal epithelial (HPDE) cells transiently or stably expressing PDX-1 or green fluorescent protein (GFP) PDX-1, with or without cotransfection of PDX-1 short hairpin RNA (shRNA). In vivo tumor formation was carried out in severe combined immunodeficiency (SCID) mice with subcutaneous injection of HEK 293 and MIA PaCa2 stably transfected cells. Cell cycle was analyzed by Western blot or immunostaining. Microarray of RNA from pancreatic adenocarcinoma cells with and without PDX-1 shRNA was performed and analyzed. RESULTS: Transient and stable expressing PDX-1 significantly increased cell proliferation and invasion in HEK 293, human pancreatic ductal epithelial (HPDE), and MIA PaCa2 cells versus controls (P < .05), human PDX-1 shRNA reversed these effects. Expression of PDX-1 significantly increased colony formation in HEK 293, HPDE, and MIA PaCa2 cells versus controls in vitro (P < .05). PDX-1 promoted HEK 293 and MIA PaCa2 tumor formation in SCID mice as compared with that of control (P < .05). PDX-1 overexpression disrupted cell cycles proteins. PDX-1 expression was confirmed by Western blot and tracked by viewing of GFP-PDX-1 expression. Microarray data support an oncogenic role of PDX-1 in pancreas cancer cells. CONCLUSIONS: PDX-1 induced increased cell proliferation, invasion, and colony formation in vitro, and resulted in markedly increased HEK 293 and MIA PaCa2 tumor formation in SCID mice. These data suggest that PDX-1 is a potential oncogene that regulates tumorigenesis.
BACKGROUND:Pancreatic-duodenal homeobox 1 (PDX-1) is a transcription factor that regulates embryologic pancreas development and insulin expression in the adult islet; however, it is overexpressed in many types of cancer, including pancreatic cancer. The purpose of this study was to investigate the role of PDX-1 in tumorigenesis in human cells. METHODS: In vitro cell proliferation, invasion, and transformation were performed in humanembryonic kidney cell line (HEK 293), pancreatic cancer cell line MIA PaCa2, and humanpancreatic ductal epithelial (HPDE) cells transiently or stably expressing PDX-1 or green fluorescent protein (GFP) PDX-1, with or without cotransfection of PDX-1 short hairpin RNA (shRNA). In vivo tumor formation was carried out in severe combined immunodeficiency (SCID) mice with subcutaneous injection of HEK 293 and MIA PaCa2 stably transfected cells. Cell cycle was analyzed by Western blot or immunostaining. Microarray of RNA from pancreatic adenocarcinoma cells with and without PDX-1 shRNA was performed and analyzed. RESULTS: Transient and stable expressing PDX-1 significantly increased cell proliferation and invasion in HEK 293, humanpancreatic ductal epithelial (HPDE), and MIA PaCa2 cells versus controls (P < .05), humanPDX-1 shRNA reversed these effects. Expression of PDX-1 significantly increased colony formation in HEK 293, HPDE, and MIA PaCa2 cells versus controls in vitro (P < .05). PDX-1 promoted HEK 293 and MIA PaCa2 tumor formation in SCIDmice as compared with that of control (P < .05). PDX-1 overexpression disrupted cell cycles proteins. PDX-1 expression was confirmed by Western blot and tracked by viewing of GFP-PDX-1 expression. Microarray data support an oncogenic role of PDX-1 in pancreas cancer cells. CONCLUSIONS:PDX-1 induced increased cell proliferation, invasion, and colony formation in vitro, and resulted in markedly increased HEK 293 and MIA PaCa2 tumor formation in SCIDmice. These data suggest that PDX-1 is a potential oncogene that regulates tumorigenesis.
Authors: Kyoko Kojima; Selwyn M Vickers; N Volkan Adsay; Nirag C Jhala; Hyung-Gyoon Kim; Trenton R Schoeb; William E Grizzle; Christopher A Klug Journal: Cancer Res Date: 2007-09-01 Impact factor: 12.701
Authors: Juan Ma; Minhu Chen; Jide Wang; Harry H X Xia; Senlin Zhu; Yingjie Liang; Qing Gu; Liang Qiao; Yun Dai; Bing Zou; Zesong Li; Yusheng Zhang; Huiyao Lan; Benjamin C Y Wong Journal: Carcinogenesis Date: 2008-05-13 Impact factor: 4.944
Authors: Mark A Feanny; Shawn P Fagan; Nikiforos Ballian; Shi-He Liu; Zhijun Li; Xiaoping Wang; William Fisher; F Charles Brunicardi; Narasimhaswamy S Belaguli Journal: J Surg Res Date: 2007-06-20 Impact factor: 2.192
Authors: Patrick W Heiser; David A Cano; Limor Landsman; Grace E Kim; James G Kench; David S Klimstra; Maketo M Taketo; Andrew V Biankin; Matthias Hebrok Journal: Gastroenterology Date: 2008-07-09 Impact factor: 22.682
Authors: Sara Jonmarker; Axel Glaessgen; W David Culp; Pavel Pisa; Rolf Lewensohn; Peter Ekman; Alexander Valdman; Lars Egevad Journal: APMIS Date: 2008-06 Impact factor: 3.205
Authors: Marina Pasca di Magliano; Andrew V Biankin; Patrick W Heiser; David A Cano; Pedro J A Gutierrez; Therese Deramaudt; Davendra Segara; Amanda C Dawson; James G Kench; Susan M Henshall; Robert L Sutherland; Andrzej Dlugosz; Anil K Rustgi; Matthias Hebrok Journal: PLoS One Date: 2007-11-07 Impact factor: 3.240
Authors: Guisheng Zhou; Shi-He Liu; Kelly M Shahi; Hua Wang; Xueyan Duan; Xia Lin; Xin-Hua Feng; Min Li; William E Fisher; Francesco J Demayo; David Dawson; F Charles Brunicardi Journal: Mol Endocrinol Date: 2012-06-05
Authors: G Zhou; J Yu; A Wang; S-H Liu; J Sinnett-Smith; J Wu; R Sanchez; J Nemunaitis; C Ricordi; E Rozengurt; F C Brunicardi Journal: Curr Mol Med Date: 2016 Impact factor: 2.222
Authors: J Wu; S Liu; J Yu; G Zhou; D Rao; C M Jay; P Kumar; R Sanchez; N Templeton; N Senzer; P Maples; J Nemunaitis; F C Brunicardi Journal: Cancer Gene Ther Date: 2014-01-24 Impact factor: 5.987
Authors: Y Wang; Y Zhang; J Yang; X Ni; S Liu; Z Li; S E Hodges; W E Fisher; F C Brunicardi; R A Gibbs; M-C Gingras; M Li Journal: Curr Mol Med Date: 2012-03 Impact factor: 2.222
Authors: Thomas S Frank; Xiaotian Sun; Yuqing Zhang; Jingxuan Yang; William E Fisher; Marie-Claude Gingras; Min Li Journal: Cancer Lett Date: 2015-04-15 Impact factor: 8.679